Age-dependent decline of -cell function in type 1 diabetes after diagnosis: a multi-centre longitudinal study
Woerle HJ, Carneiro L, Derani A, Goke B, Schirra J
Boesen notes, In drug litigation, we win cases not by volume, but by precisionrecords that prove exposure, diagnosis, and mechanism leave no room for the defense to claim coincidence. For answers to your questions, call: Preserving Evidence Before You File Evidence disappears quickly in pharmaceutical cases, which is why documentation must begin the moment you suspect complications
Fadini GP, Avogaro A: Cardiovascular effects of DPP-4 inhibition: Beyond GLP-1
De orale melanotische macula is de meest voorkomende gepigmenteerde afwijking in de mond: een platte, goed omschreven bruine of zwarte vlek, meestal kleiner dan een centimeter, die het vaakst voorkomt op de lip of het wangslijmvlies, maar ook op de tong kan verschijnen
No, the FDA has not approved any transdermal patch for GLP-1 delivery